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In recent years, several studies have described the clinical impact of bacterial infection associated with 
transfusion of platelet concentrates (PCs). Among the blood components, PCs are responsible for the 
highest rates of bacterial contamination as well as septic transfusion reactions. We assessed antimicrobial 
susceptibility profile, resistance to methicillin (MRCoNS), and resistance to macrolides, lincosamides 
and streptogramins of group B (MLSB) of 16 coagulase-negative staphylococci (CoNS) isolates from 
an investigation in 691 PCs bags. We then compared conventional and automated phenotypic methods, 
disc diffusion test (DD) and VITEK® 2, respectively as well as phenotypic and genotypic methods 
(Polymerase Chain Reaction - PCR). All CoNS were susceptible to vancomycin. The disc diffusion 
test characterized 18.75% as MRCoNS and 37.5% with inducible resistance to MLSB (iMLSB), and 
with VITEK® 2, 6.3% and 31.25%, respectively. The mecA gene was detected in 18.75% and the erm 
gene in 31.25% of the isolates. In this study, we found equal percentage values between presence of the 
mecA gene by PCR and resistance to methicillin using cefoxitin by DD test, evidence of the erm gene 
by PCR, and iMLSB resistance by automation (VITEK® 2). Moreover, we identified three strains with 
beta-lactamase overproduction, and the occurrence of a bigger mistake was verified when automation 
was compared with DD test. And we observed that D-test was the most reliable for the detection of 
iMLSB resistance in Staphylococcus sp.
Uniterms: Bacterial resistance. Staphylococcus sp. Platelet concentrates. MecA. Erm.
INTRODUCTION
Bacterial contamination of blood components has 
probably been the first disease transmitted by transfusion 
(Blajchman, 1995). Despite bacterial sepsis associated 
to transfusion being known for a long time, it remains 
a serious health problem. Several measures have been 
deployed to prevent and detect bacterial contamination of 
platelet concentrates (PCs). These actions have reduced 
but not eliminated the risk of septic transfusion reactions 
(Eder, Goldman, 2011). Besides the risk of bacterial 
contamination of blood components, current studies seek 
to detect and reduce the risk of transfusion-related acute 
lung injury (TRALI), a syndrome characterized by acute 
respiratory distress following transfusion (Eder, Dy, 
O’Neill, 2016).
PCs are blood components with the highest bacterial 
contamination rate and usually responsible for most of 
septic transfusion reactions (Chang et al., 2004). This 
type of bacterial contamination due to PCs infusion is 
much higher than other types of transfusion-transmitted 
infections (Jacobs, Palavecino, Yomtovian, 2001; 
Goodnough, Sander, Brecher, 2003; Vasconcelos et al., 
2004).
Gram-positive cocci are the most common 
contaminants in PCs and coagulase-negative staphylococci 
(CoNS) are the main responsible for septic transfusion 
reactions (Greco et al., 2008). They are frequently 
associated with hospital infections, particularly in 
immunocompromised patients (Stoll et al., 2002). 
R. Martini, R. Hörner, D. A. S. Graichen
Braz. J. Pharm. Sci. 2017;53(1):e15195Page 2 / 11
Although CoNS form part of the normal flora of humans, 
they are acknowledged as important pathogens, causing 
a wide variety of infections. They are isolated from skin 
and soft tissue infections, respiratory and lower urinary 
tract, and specifically bloodstream infections (Landrum 
et al., 2012).
In recent years, due to the high rate of hospital 
infections associated with antimicrobial resistance, 
resistance patterns of CoNS have become the study source 
of many researchers worldwide (De Giusti et al., 1999).
The classic mechanism of resistance to methicillin 
present in CoNS (coagulase-negative staphylococci 
resistant to methicillin - MRCoNS), encoded by the 
mecA gene is well documented, conferring resistance to 
all beta-lactam agents. Studies show that there has been a 
substantial increase in MRCoNS isolation rates in hospital 
infections, including Brazil, where resistance rates are 
among 50-80%, varying according to bacterial species and 
patient’s demographic data (Marshall et al., 1998; Hussain 
et al., 2000; Ferreira et al., 2003; Palazzo, Darini, 2006).
CoNS may also be resistant to macrolides, 
lincosamides and streptogramins of group B agents (MLSB), 
which may be constitutive (cMLSB) or inducible (iMLSB). 
In the constitutive expression, resistance to erythromycin 
and clindamycin is detected in a normal antibiogram. 
However, in the inducible form, resistance to erythromycin 
and false susceptibility to clindamycin are detected. It is 
recommended that the conventional phenotypic detection 
of iMLSB resistance is performed by D-test (Clinical 
and Laboratory Standards Institute, 2014). There are 
three mechanisms of Staphylococcus resistance linked 
to the MLSB group: target modification of ribosomes by 
methylase, mediated by erm genes (Nakajima, 1999); efflux 
mechanisms mediated by msrA gene (Matsuoka et al., 1999) 
and characterized as MSB phenotype, conferring resistance 
to macrolides only (Matsuoka et al., 2002; David, Pimentel, 
Freire, 2005); and antibiotics enzymatic inactivation 
(Roberts et al., 1999). Nevertheless, the predominant form 
is target modification (Roberts et al., 1999; Leclercq, 2002).
A study publ ished by our  research  group 
emphasizes the importance of recognizing sepsis 
caused by contaminated PCs transfusion, specifically 
in immunocompromised patients, since bacterial sepsis 
associated to platelet transfusion is nowadays the most 
common infectious complication of transfusion medicine 
(Martini et al., 2012).
The aim of this study was to assess the susceptibility 
profile against antimicrobials as well as to research the 
typical resistance to methicillin and to MLSB group 
by phenotypic, conventional and automation methods, 
including mecA and erm genes.
MATERIAL AND METHODS
Inclusion criteria for isolated bacterial and 
reference standard strains
A total of 16 CoNS were isolated through a study 
on bacterial investigation carried out in 691 PCs bags, 
collected during 2009/2010, from the Blood Bank of the 
city of Santa Maria, Rio Grande do Sul State (HEMORGS/
SM, RS),
The following strains of international reference 
standard (American Type Culture Collection - ATCC) 
were used as controls in genotypic and phenotypic tests: 
Staphylococcus aureus ATCC 43300, ATCC 25923, 
BAA977, BAA976 and ATCC 29213.
Antimicrobial Susceptibility Testing by 
disk diffusion test (DD) and VITEK® 2; 
and determination of minimum inhibitory 
concentration (MIC) of vancomycin
For the performance of phenotypic tests, strains 
previously stored in Trypticase Soy Broth 15% glycerol 
were activated in Mueller Hinton agar and incubated at 
35±2 °C for 24 hours. 
We performed antimicrobial susceptibility testing 
using two methods, the conventional method of disk 
diffusion (DD) and the automated method VITEK® 
2. Antimicrobial susceptibility testing was performed 
using disk diffusion test (DD) following the cutoff 
points recommended by the Clinical and Laboratory 
Standards Institute (Clinical and Laboratory Standards 
Institute, 2014), and susceptibility testing was performed 
by VITEK® 2 automated method, according to the 
manufacturer’s standards (bioMérieux). Vancomycin 
minimum inhibitory concentration (MIC) was made by 
the broth micro-dilution method, performed in duplicate 
(Clinical and Laboratory Standards Institute, 2014).
Analysis of resistance genes
For the genotypic testing, deoxyribonucleic acid 
extraction (DNA) was carried out by heating shock. 
Bacterial isolates were grown on Trypticase Soy Agar 
and then incubated at 35 ± 2°C for 18 to 24 hours. 
Subsequently, a dense bacterial suspension with 4-5 
isolated colonies was prepared in an Eppendorff type 
microtube containing 500 uL autoclaved Milli Q water. 
This suspension was homogenized by vortex and placed 
in water bath at 100 °C for 15 minutes. The microtube 
was subjected to heating shock (on ice) for 5 minutes 
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and centrifuged at 11,000 rotations per minute (rpm) for 
20 minutes. The supernatant (containing the DNA) was 
transferred to another microtube which was frozen at -20 
°C (Nogueira et al., 2004; Freschi, Carvalho, Oliveira, 
2005; Scheffer, 2008; Aguilar, 2009). DNA extraction 
by heating shock was confirmed by the 16S rRNA gene 
amplification, obtaining a high quality DNA.
Amplification of 16S ribosomal RNA (rRNA)
The extracted DNA was subjected to electrophoresis 
in 1.0% agarose gel to verify DNA presence in the 
extracted material. The 16S rRNA was amplified by 
Polymerase Chain Reaction (PCR) and the following 
primers were used: 5’-GTAGTCCACGCCGTAAAC-3’ 
and 5’-TAAACCACATGCTCCACC-3 (Li et al., 2009).
Identification of MRCoNS
Identification of bacterial species isolated from 
infected PCs bags was performed by VITEK® 2 automated 
system. To study phenotypic resistance to methicillin 
were used discs of cefoxitin (30 µg) and MIC cefoxitin 
(VITEK® 2). Results were interpreted according to the 
criteria established by the CLSI (Clinical and Laboratory 
Standards Institute, 2014).
To identify the presence of mecA gene, the following 
sequences were used: mecA_F AGT TAG ATT GGG ATC 
ATA GCG and mecA_R CGA TGC CTA TCT CAT ATG 
CTG (Ludwig Biotec®). The primers used for mecA gene 
testing were designed using the PBP2a protein structure 
made in the Laboratory of Molecular Biology and 
Sequencing - LabDros (Lim, Strynadka, 2002). The best 
mold region for primer design is the non-variable portion 
of PBP2a - between 27 and 326 amino acids - being in 
base pairs, corresponding to the region between 81 and 
978 nucleotides. The GU301106 reference sequence 
from GenBank was used as the primer’s choice. The size 
of amplicons generated by the amplification using these 
primers is 145 bp, and they were checked in 0.8% agarose 
gel. MRCoNS identification was followed as suggested by 
Kearns et al. (1999).
Detection of macrolide-lincosamide-
streptogramin B (MLSB) resistance
Double disk or Diffusion Test (D-test) was performed 
using the DD technique, following the standards 
recommended by the CLSI (Clinical and Laboratory 
Standards Institute, 2014). ermABC genes determination 
was carried out according to Coutinho et al. (2010) 
Primers’ sequence was: ermA_F 5’-GTT CAA GAA CAA 
TCA ATA CAG AG-3’ and ermA_R 5’-GGA TCA GGA 
AAA GGA CAT TTT AC-3’; ermB_F 5’-CCG TTT ACG 
AAA TTG GAA CAG GTA AAG GGC-3’ and ermB_R 
‘5-GAA TCG AGA CTT GAG TGT GC-3’; ermC_F 5’-
GCT AAT ATT GTT TAA ATC GTC AAT TCC-3’ and 
ermC_R 5’-GGA TCA GGA AAA GGA CAT TTT AC-3’.
Statistical analysis
We proceeded to sensitivity assessment and methods 
specificity tested in the detection of each resistance 
mechanism (Bonita, Beaglehole, Kjellström, 2010). 
Ethical considerations
This s tudy was approved by the Research 
Ethics Committee (CEP) of UFSM under the number 
0285.0.243.000-09.
RESULTS AND DISCUSSION
Automated bacterial identification - VITEK® 2
From the total of 16 isolates of CoNS obtained 
through a research on bacterial contamination carried out 
in 691 PCs from HEMORGS/SM, five were identified 
as Staphylococcus haemolyticus (31.25%), four as 
Staphylococcus epidermidis (25%), four as Staphylococcus 
warneri (25%), and three as Staphylococcus saprophyticus 
(18.75%). The bacterial species isolated from contaminated 
PCs bags were identified by the automated system Vitek® 
2. All organisms isolated in contaminated PCs were 
identified as CoNS, similar to the results found by several 
authors (Hsueh et al., 2008; Martínez, Tarrand, Lichtiger, 
2010; Walther-Wenke et al., 2010). Currently, CoNS 
represent one of the major nosocomial pathogens and S. 
epidermidis and S. haemolyticus are the most significant 
species. Moreover, the increasing rates of antibiotic 
resistance are an even greater problem for CoNS than for 
Staphylococcus aureus, limiting our therapeutic options 
(Becker, Heilmann, Peters, 2014).
Comparison of susceptibility profile between disk 
diffusion test (DD) and VITEK® 2 
In this study, there was discrepancy in the 
susceptibility assessment between DD and automation 
methods with cl indamycin,  sulfamethoxazole/
trimethoprim, erythromycin, gentamicin and norfloxacin 
antibiotics (in descending order), and agreement was 
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observed only in three (No. 11, 12 and 14) of the 16 
analyzed samples as they showed the same profile of 
antimicrobial susceptibility (Table I).
Studies by other authors confirm our findings 
when these two methods are compared (VITEK® 2 and 
DD test - considered reference methods), reporting the 
occurrence of much higher error (VME), higher error 
(ME), and lowest error (MiE) with the VME prevalence 
profile (Sapino et al., 2012; Paim, Cantarelli, D’Azevedo, 
2014), in susceptibility assessed by the automated method. 
All CoNS were resistant to penicillin G and penicillin 
(automated and DD test, respectively), and by DD test 
62.5% were resistant to clindamycin and erythromycin 
against 31.25% and 43.75%, respectively, by automation. 
Studies have reported CoNS high resistance levels to 
penicillin, clindamycin and erythromycin (Bernardi, 
Pizzolitto, Pizzolitto, 2007; Melo et al., 2007; Rigatti et 
al., 2010). All samples were susceptible to vancomycin, a 
similar result to that found in the studies mentioned above. 
In our study vancomycin MIC was between 0.5 µg/mL a 
2 µg/mL.
Assessment of Methicillin-Resistant Coagulase-
Negative Staphylococci (MRCoNS)
In relation to methicillin resistance in CoNS, three 
samples (18.75%) were resistant to cefoxitin in DD, and by 
VITEK® 2 one sample was resistant (Table II). Regarding 
CoNS, the standardized tests reporting MRCoNS strains 
are: agar dilution, DD technique and broth micro-dilution 
(Clinical and Laboratory Standards Institute, 2014). In the 
study developed by John et al. (2009), authors showed that, 
VITEK® 2 did not detect methicillin resistance against 
S. aureus and most of the CoNS. By the PCR method, 
considered by many authors the gold standard one for the 
phenotypic testing comparison (Cafiso et al., 2004; Ruzicka 
et al., 2004; Gad et al., 2009), the mecA gene presence was 
detected in three samples (18.75 %), which were susceptible 
to cefoxitin in DD test and VITEK® 2 (Table II).
Studies show that methicillin resistance in 
Staphylococcus occurs mainly due to the production of 
modified penicillin binding protein (PBP2a) encoded by 
the mecA gene. This less frequent resistance, however, 
may also be due to the beta-lactamase overproduction by 
oxacillin inactivation, resulting in partial hydrolysis of the 
beta-lactamase ring (borderline resistance to methicillin 
- BORSA) or the presence of a PBP with low affinity to 
oxacillin (MODSA) (Tomasz et al., 1989; Ito et al., 2003; 
Rossi, Andreazzi, 2005). In these last two resistance 
mechanisms to methicillin, bacteria do not carry the mecA 
gene (Mohanasoundaram, Lalitha, 2008). 
We suggest the identification of three MRCoNS 
strains with overproduction of beta-lactamase enzyme, 
which rarely occurs when Staphylococcus strains show 
resistance in DD test and do not have the mecA gene. 
The treatment for infections caused by MRCoNS may be 
performed with linezolid, teicoplanin, and vancomycin, as 
well as alternative drugs such as macrolides, clindamycin, 
and trimethoprim/sulfamethoxazole (Rossi, Andreazzi, 
2005).
Resistance to methicillin and beta-lactamase 
overproduction are the main causes of discordant 
results among phenotypic and genotypic tests to detect 
MRCoNS (Ghoshal et al., 2004). Research of this kind 
of resistance by phenotypic methods can be complex due 
to the heterogeneous expression of many strains, which 
may also be influenced by growth conditions (Chambers, 
1997).
Recent surveys have detected a rare homologous 
gene to mecA in S. aureus strains isolated from humans 
and animals with phenotypic resistance to methicillin, 
found through DD test with cefoxitin, which did not show 
the mecA gene when specific primers for this gene were 
used (Cuny et al., 2011; Shore et al., 2011; Cartwright 
et al., 2013). This gene was initially called mecALGA251 and 
later designated as mecC (Ito et al., 2012). This mecC 
gene has also been reported in CoNS as Staphylococcus 
stepanovicii, Staphylococcus xylosus and Staphylcoccus 
scirui (Harrison et al., 2013a, 2013b; Loncaric et al., 
2013). As already suggested for the mecA gene, we can 
probably infer that the origin of the mecC gene is also 
among the CoNS (Tsubakishita et al., 2010; Couto et al., 
2013). Although mecC gene detection is rare and reported 
only in Europe so far, this gene is a potential diagnosis 
problem and triggers several issues for future studies 
(Paterson, Harrison, Holmes, 2014).
Analysis of macrolide-lincosamide-streptogramin 
B (MLSB) resistance
The conventional phenotypic analysis (DD) of 
resistance to MLSB antimicrobials, carried out with the 
disk approximation test - D-test, characterized six samples 
(37.5%) with inducible (iMLSB) and two samples (12.5%) 
with constitutive phenotype (cMLSB). On the other hand, 
the MSB phenotype was not detected by DD test (Table 
III). Coutinho et al. (2010) analysis of CoNS through the 
DD method found three different phenotypes, distributed 
as follows: 46.7% cMLSB and 3.3% of the other two 
phenotypes (iMLSB and MSB). Through the automated 
method, our study detected 31.25% (5 of 16) iMLSB and 
6.25% (1 of 16) MSB (Table III).
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As mentioned in the paragraph above, no CoNS of 
our research showed an efflux mechanism (MSB phenotype) 
by the D-test result. However, when automation was used 
(VITEK® 2) one sample showed the MSB phenotype: this 
one showed the iMLSB phenotype by DD test.
The erm gene was detected in five PCR samples 
(31.25%). One (6.25%) containing ermA gene and four 
(25%) ermC gene; the ermB gene was not detected in 
our study. Coutinho et al. (2010) identified the presence 
of ermA gene in 29.6% of samples. Regarding the 
genotypic test, our index showed 67% of sensitivity and 
86% of specificity, when compared to D-test, which was 
considered a reference in this study.
Lavallée et al .  (2010) compared detection 
methodologies for iMLSB resistance only, in a collection of 
163 Staphylococcus with resistant or intermediate profile 
to erythromycin and susceptible profile to clindamycin. In 
our study, through the performance of the same phenotypic 
tests and erm genes detection by PCR, 93% and 100% 
specificity and sensitivity were found, respectively, for 
VITEK® 2. Therefore, they concluded that automation has 
failed to detect iMLSB resistance in ten strains (10/163), 
resulting in a negative predictive value (NPV) of 74% 
(Lavallée et al., 2010). When comparing these same 
methodologies, in our study we found 73% of NPV.
The authors cited above concluded that D-test is the 
most simple and reliable technique to detect this resistance 
in CoNS strains. They also concluded that agar dilution 
and VITEK® 2 are not as sensitive as D-test within 
24 hours for CoNS strains for the detection of iMLSB 
(Lavallée et al., 2010). 
The discrepancy between results given by the 
different methods, i.e., inhibition in DD test and gene 
absence in PCR may be justified by the presence of 
another gene, ermY, which was not the subject of this 
research. However, there are reports of its presence in 
Staphylococcus (Roberts et al., 1999). The other reason for 
strains showing the iMLSB phenotype that do not contain 
the erm gene is still not clear (Roberts et al., 1999), but 
it is attributed to possible changes in the local targets of 
primers for these genes (Lavallée et al., 2010). Our study 
confirmed the superiority of D-test when compared to 
VITEK®2 in iMLSB detection.
CONCLUSIONS
As for resistance genes showed by the different 
species studied, it was found that one S. epidermidis and 
one S. warneri showed the mecA gene and the erm gene. 
These two species also showed the highest resistance rate 
to methicillin. Through the antimicrobial susceptibility 
profile, obtained by the DD technique, approximately 
50% of strains were characterized as multi-drug resistant 
(MDR), being resistant to more than three classes of 
antimicrobials.
The results of this study are a reminder to health 
professionals regarding the CoNS antimicrobial 
susceptibility profile, since most of them were resistant to 
antimicrobials (A and B-CLSI ratings) by the conventional 
assessment method. Also, half of the isolates were 
resistant to multiple classes of antibiotics, which directly 
influence on morbidity and mortality, specifically in 
immunocompromised patients, who often develop 
infections from resident microorganisms of the skin flora 
TABLE II - Analysis of MRCoNS of the 16 coagulase-negative staphylococci isolates from Platelet Concentrates through the 
phenotypic tests of Cefoxitin Disk Diffusion (DD), screening of cefoxitin by VITEK® 2, research of the gene mecA by Polymerase 
Chain Reaction
Samples 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Species
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CFO (DD) S S R S S S R S R S S S S S S S
Screening of CFO 
(automation) - - - - - - + - - - - - - - - -
mecA - - - - - - - + - - - - - - + +
*Research conducted only with strains that showed phenotypic resistance to methicillin; CFO = Cefoxitin; DD = Qualitative 
methodology of disk diffusion; S = Susceptible; I = Intermediate; R = Resistant; “-“= absence; “+”= presence.
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such as CoNS. Restrictive policy with antimicrobials 
as well as immediate and correct prescription should be 
encouraged in order to control bacterial resistance.
This is in fact the first study conducted in Brazil 
that investigates susceptibility profile and resistance 
mechanisms of microorganisms isolated from PCs bags.
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